A New Type of Insulin Product
Although there are many available insulin products for the treatment of diabetes, research continues to uncover new therapies that increase convenience. Many insulin users have complained about their need for multiple daily injections, and those who wear insulin pumps are often burdened by the bulk. To increase comfort and compliance, Novo Nordisk has recently released a new insulin product called Levemir® (insulin detemir). Levemir® was approved for once or twice daily dosing for those with type I diabetics or type II diabetics who require insulin. This product is long acting, like Lantus® insulin, which involves fewer injections. Initially, a dose of 10 units in the evening or at bedtime is used. Doses may be increased or decreased according to response. Levemir® should not be mixed in the same syringe with any other insulin products or used in an insulin pump. Glucose monitoring is recommended with its use. As with other insulin products, the most common side effects are low blood sugar and allergic reactions. This new insulin comes in a vial or pre-filled syringe that should be kept under refrigeration.